AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2018
Aug 21, 2018
35599_dirs_2018-08-21_75c3108e-fed3-4324-92da-e42e082fabb1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2018-08-20
Reporting Person: Raykov Rosty (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-20 | Common Stock | M | 17050 | $1.44 | Acquired | 40470 | Direct |
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20